Nothing Special   »   [go: up one dir, main page]

Poelstra et al., 1990 - Google Patents

Intraglomerular platelet aggregation and experimental glomerulonephritis

Poelstra et al., 1990

View PDF
Document ID
3955155085184154656
Author
Poelstra K
Hardonk M
Koudstaal J
Bakker W
Publication year
Publication venue
Kidney international

External Links

Snippet

Intraglomerular platelet aggregation and experimental glomerulonephritis. Oxygen free radical production inhibits ADPase-mediated antithrombotic action. Different forms of experimental glomerulonephritis (GN) are characterized by early glomerular influx of …
Continue reading at www.sciencedirect.com (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Similar Documents

Publication Publication Date Title
Poelstra et al. Intraglomerular platelet aggregation and experimental glomerulonephritis
Hart et al. Demonstration and characterization of Ia-positive dendritic cells in the interstitial connective tissues of rat heart and other tissues, but not brain.
Cowan et al. Elafin, a serine elastase inhibitor, attenuates post-cardiac transplant coronary arteriopathy and reduces myocardial necrosis in rabbits afer heterotopic cardiac transplantation.
Ludwig et al. Differential sorting of lysosomal enzymes in mannose 6‐phosphate receptor‐deficient fibroblasts.
Schrijver et al. Antiglomerular basement membrane nephritis in beige mice. Deficiency of leukocytic neutral proteinases prevents the induction of albuminuria in the heterologous phase.
EP0951292B1 (en) Treating an ischemic disorder and improving stroke outcome
US6316403B1 (en) Methods for treating an ischemic disorder and improving stroke outcome
Ryan et al. Tumor necrosis factor-induced endothelial tissue factor is associated with subendothelial matrix vesicles but is not expressed on the apical surface
Simon et al. Neutrophil-induced injury of rat pulmonary alveolar epithelial cells.
Issekutz et al. The effect of vasodilator prostaglandins on polymorphonuclear leukocyte infiltration and vascular injury.
US8128963B2 (en) Methods for treating ischemic disorders using carbon monoxide
Heeringa et al. Expression of iNOS, eNOS, and peroxynitrite-modified proteins in experimental anti-myeloperoxidase associated crescentic glomerulonephritis
Jansen et al. In situ complement activation in porcine membranoproliferative glomerulonephritis type II
WO1998013058A9 (en) Methods for treating an ischemic disorder and improving stroke outcome
DE69133049T2 (en) ANTIBODIES AGAINST THE UROKINAS RECEPTOR AND THEIR USE
Sinzinger Role of platelets in atherosclerosis
Wu et al. Fibrinogen mediates platelet-polymorphonuclear leukocyte cooperation during immune-complex glomerulonephritis in rats.
Gotoh et al. Enhancement of the expression of a rat neutrophil-specific cell surface antigen by activation with phorbol myristate acetate and concanavalin A.
MASUZAWA et al. Immunocytochemical localization of Na+, K+-ATPase in the canine choroid plexus
Uragoh et al. A novel immunohistochemical method for in vivo detection of endotoxin using horseshoe crab factor C.
STRAUS Location of the antigen, antibody and antigen-antibody complexes in delayed-type hypersensitivity skin reactions to horseradish peroxidase
Poelstra Glomerular adenine nucleotidases: a study into the anti-thrombotic and anti-inflammatory activity of the rat kidney
US6750201B1 (en) Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator
WO1994000143A1 (en) Blocking intercellular interactions with cd43 chimeric molecules
Suzuki et al. Ultrastructural study of human myeloma cells in relation to its function